Skip to content
★ Sign in to follow
SJ
Total declarations
31
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (24 ops.)
€1.1M

Latest filing published 02 Apr 2019 for Abbott Laboratories.

Filing timeline

BuySale
Sharon J. Bracken

Insider track record

Disclosed buys
0
Disclosed sells
24
Signal history

Sharon J. Bracken: trading record in brief

Sharon J. Bracken discloses dealings in Abbott Laboratories to SEC (Form 4). Between 10 July 2017 and 31 March 2019, the trades on record add up to 31 filings.

No open-market purchase appears, only 24 sales worth €1.1M. Besides market trades, the filings include 6 share grants. So far in 2019, the count stands at no purchases and 6 sales.

On 2 April 2019 came the latest disclosure, a transaction in Abbott Laboratories. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Sharon J. Bracken

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations30 total
  • ●
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    38,983 shares0Common shares without par valueSEC:0001179110-19-004522:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    7,783 USD29SEC
    100 shares@ US$77.830.6% of flowCommon shares without par valueSEC:0001179110-19-003619:2
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    31,132 USD29SEC
    400 shares@ US$77.832.6% of flowCommon shares without par valueSEC:0001179110-19-003619:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    334,669 USD32SEC
    4,300 shares@ US$77.8327.9% of flowCommon shares without par valueSEC:0001179110-19-003619:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    46,704 USD29SEC
    600 shares@ US$77.843.9% of flowCommon shares without par valueSEC:0001179110-19-003619:4
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    361,282 USD14SEC
    4,678 shares@ US$77.2329.9% of flowCommon shares without par valueSEC:0001179110-19-003110:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    95,472 USD30SEC
    1,224 shares@ US$78.007.9% of flowCommon shares without par valueSEC:0001179110-19-003110:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    17,292 shares0Common shares without par valueSEC:0001179110-19-002636:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    112,372 USD30SEC
    1,532 shares@ US$73.356.8% of flowCommon shares without par valueSEC:0001179110-18-011959:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    7,335 USD29SEC
    100 shares@ US$73.350.4% of flowCommon shares without par valueSEC:0001179110-18-011959:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    7,336 USD29SEC
    100 shares@ US$73.360.4% of flowCommon shares without par valueSEC:0001179110-18-011959:2
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    40,073 USD29SEC
    615 shares@ US$65.162.3% of flowCommon shares without par valueSEC:0001179110-18-010031:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    16,369 USD23SEC
    259 shares@ US$63.200.9% of flowCommon shares without par valueSEC:0001179110-18-009885:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    31,532 USD11SEC
    505 shares@ US$62.441.8% of flowCommon shares without par valueSEC:0001179110-18-009647:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    17,568 USD23SEC
    300 shares@ US$58.561.0% of flowCommon shares without par valueSEC:0001179110-18-006429:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    23,424 USD23SEC
    400 shares@ US$58.561.3% of flowCommon shares without par valueSEC:0001179110-18-006429:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    26,352 USD23SEC
    450 shares@ US$58.561.5% of flowCommon shares without par valueSEC:0001179110-18-006429:2
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    58,570 USD23SEC
    1,000 shares@ US$58.573.2% of flowCommon shares without par valueSEC:0001179110-18-006429:3
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    96,432 USD30SEC
    1,600 shares@ US$60.275.2% of flowCommon shares without par valueSEC:0001179110-18-003787:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    12,054 USD29SEC
    200 shares@ US$60.270.7% of flowCommon shares without par valueSEC:0001179110-18-003787:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    18,078 USD29SEC
    300 shares@ US$60.261.0% of flowCommon shares without par valueSEC:0001179110-18-003787:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    124,491 USD12SEC
    2,056 shares@ US$60.556.8% of flowCommon shares without par valueSEC:0001179110-18-003300:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    62,053 USD29SEC
    1,053 shares@ US$58.933.4% of flowCommon shares without par valueSEC:0001179110-18-003300:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    24,481 shares0Common shares without par valueSEC:0001179110-18-002530:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    89,119 USD29SEC
    1,588 shares@ US$56.125.0% of flowCommon shares without par valueSEC:0001179110-17-014780:0

25 of 30 declarations